Economic Burden of Irritable Bowel Syndrome: Proposed Strategies to Control Expenditures
It has been suggested that the annual direct costs for irritable bowel syndrome (IBS) are now around $US41 billion in the 8 most industrialised countries. This paper reviews the data on calculations of direct costs. The true economic burden is unclear, as there are insufficient data on indirect costs other than absenteeism from work and intangible costs cannot be estimated, particularly since presenters with IBS constitute only a subset of the patients with such symptoms in the community. Strategies to reduce direct costs must include physician and patient education, paramedical-based education and therapy, lay support groups, early consideration of psychosocial issues and psychological treatments, avoidance of unnecessary investigations and optimising the doctor-patient relationship. Indirect and intangible costs could be effectively reduced by novel, effective (not only efficacious) therapies.
Year of publication: |
2000
|
---|---|
Authors: | Camilleri, Michael ; Williams, Donald E. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 17.2000, 4, p. 331-338
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Alosetron | Antidepressants | Cost of illness | Diet | Irritable bowel syndrome | Medical education | Patient education | Pharmacoeconomics | Psychotherapy | Research and development | Serotonin antagonists |
Saved in:
Online Resource
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
Persistent link: https://www.econbiz.de/10005590450
Saved in favorites
Similar items by subject
-
Maximizing Treatment Outcome in Depression: Strategies to Overcome Social Stigma and Noncompliance
Stimmel, Glen L., (2001)
-
Quality of Life in Irritable Bowel Syndrome
Lea, Richard, (2001)
-
Technology-Based Advances in the Management of Depression: Focus on the COPE(TM) Program
Greist, John H., (2000)
- More ...